Publications by authors named "Paul Liberator"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

369,039

Total Likes

9,307

Extended Reach

14,519,659

Social Features

468
S
Safety, tolerability, and immunogenicity of pentavalent meningococcal MenABCWY vaccine in healthy infants: A phase 2b randomized clinical trial.
Federico Martinon-Torres, Erik Lamberth, Silvina Natalini Martinez, Ignacio Salamanca de la Cueva, Lefteris Zolotas, Paul A Liberator

Hum Vaccin Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characterization of clinical Borrelia burgdorferi sensu lato isolates in the Netherlands over a thirty-year period.
Zhenghui Li, Jonathan T Lee, Varun Raghuraman, Lorna D Nunez, Urvi Rajyaguru, Paul A Liberator

BMC Genomics· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interlaboratory study to assess precision and reproducibility of the meningococcal antigen surface expression (MEASURE) assay to quantify factor H binding protein expression at the surface of meningococcal serogroup B strains.
Jakob Loschko, Paul Liberator, Jamie Findlow, Jason Yip, Charles Tan

Diagn Microbiol Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of Clostridioides difficile isolated from older adults during prospective population-based active surveillance at nine hospitals in Tokyo, Japan, 2018-2020.
Zhenghui Li, Ashlesh K Murthy, C Hal Jones, Kwok Lee, Urvi Rajyaguru, Paul A Liberator

Anaerobe· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance.
Yuao Zhu, Irina Yurgelonis, Stephen Noell, Qingyi Yang, Shunjie Guan, Paul Liberator

Sci Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a sequence-based OspA typing method for .
Jonathan T Lee, Zhenghui Li, Lorna D Nunez, Daniel Katzel, B Scott Perrin, Paul A Liberator

Microb Genom· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PfaSTer: a machine learning-powered serotype caller for genomes.
Jonathan T Lee, Xingpeng Li, Craig Hyde, Paul A Liberator, Li Hao

Microb Genom· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A.
Li Hao, Michelle M Kuttel, Neil Ravenscroft, Allison Thompson, A Krishna Prasad, Paul Liberator

Vaccine· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Surveillance of SARS-CoV-2 M Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid.
Jonathan T Lee, Qingyi Yang, Alexey Gribenko, B Scott Perrin, Yuao Zhu, Paul A Liberator

mBio· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverage.
Jamie Findlow, Ray Borrow, David S Stephens, Paul Liberator, Annaliesa S Anderson

Expert Rev Vaccines· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor.
James M Apgar, Robert R Wilkening, Dann L Parker, Dongfang Meng, Kenneth J Wildonger, Paul Liberator

Bioorg Med Chem Lett· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of a Four-Antigen Vaccine in Preclinical Models of Invasive Disease.
Ingrid L Scully, Yekaterina Timofeyeva, Arthur Illenberger, Peimin Lu, Paul A Liberator

Microorganisms· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad vaccine protection against Neisseria meningitidis using factor H binding protein.
Jamie Findlow, Christopher D Bayliss, Peter T Beernink, Ray Borrow, Paul Liberator

Vaccine· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary: Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates.
Paul Liberator, Robert G K Donald, Paul Balmer, Jamie Findlow, Annaliesa S Anderson

Front Microbiol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MK-5204: An orally active β-1,3-glucan synthesis inhibitor.
James M Apgar, Robert R Wilkening, Dann L Parker, Dongfang Meng, Kenneth J Wildonger, Paul Liberator

Bioorg Med Chem Lett· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribotype Classification of Isolates Is Not Predictive of the Amino Acid Sequence Diversity of the Toxin Virulence Factors TcdA and TcdB.
Zhenghui Li, Kwok Lee, Urvi Rajyaguru, C Hal Jones, Sandra Janezic, Paul Liberator

Front Microbiol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp).
Julie A Bettinger, Paul Liberator, Scott A Halperin, Wendy Vaudry, Manish Sadarangani

Vaccine· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of Neisseria meningitidis serogroup b (NmB) vaccine antigens in meningococcal disease causing isolates in the United States during 2009-2014, prior to NmB vaccine licensure.
How-Yi Chang, Jeni Vuong, Fang Hu, Paul Liberator, Alex Chen

J Infect· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States.
Naglaa Mohamed, Yekaterina Timofeyeva, Dorota Jamrozy, Eduardo Rojas, Li Hao, Paul Liberator

PLoS One· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci.
Shannon L Harris, Cuiwen Tan, Lubomira Andrew, Li Hao, Paul A Liberator

Vaccine· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct evolutionary patterns of Neisseria meningitidis serogroup B disease outbreaks at two universities in the USA.
Li Hao, Matthew T G Holden, Xin Wang, Lubomira Andrew, Sabine Wellnitz, Paul Liberator

Microb Genom· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires.
Bin Jia, Lisa K McNeil, Christopher D Dupont, Konstantinos Tsioris, Rachel M Barry, Paul A Liberator

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France.
Muhamed-Kheir Taha, Julio Cesar Hawkins, Paul Liberator, Ala-Eddine Deghmane, Lubomira Andrew

Vaccine· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meningococcal serogroup B vaccines: Estimating breadth of coverage.
Robert G K Donald, Julio Cesar Hawkins, Li Hao, Paul Liberator, Thomas R Jones

Hum Vaccin Immunother· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis